• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Polypharmacy associated with greater risk of mortality and hospitalizations in elderly

bySiwen LiuandAlex Chan
February 12, 2025
in Chronic Disease, Pharma
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Polypharmacy was associated with a greater risk of mortality and hospitalizations at one and five years. 

Evidence Rating Level: 2 (Good)

Polypharmacy, commonly defined as the use of five or more medicines, has been associated with a greater risk of adverse drug reactions (ADRs), particularly among the older population. Studies on polypharmacy and its association with sociodemographic and clinical factors have been inconsistent. This retrospective cohort study thus aimed to determine the association of polypharmacy with mortality, hospitalization, ADRs, and falls among community-dwelling adults in the UK at one and five years. This study used a random sample of patients >75 years from the Clinical Practice Research Datalink (CPRD). In total, 977 patients were analyzed (mean [SD] age, 83 [5.5] years; 351 males [36%]) and polypharmacy was present in 457 (47%) patients. At one year and five years, adjusted hazard ratios [95% confidence intervals] indicated polypharmacy was positively associated with mortality (one year: 2.37 [1.40–3.90]; five years: 1.60 [1.30–2.00]) and hospitalization (one year: 2.47 [1.40–4.30]; five years: 1.49 [1.30–1.70]). Polypharmacy was not associated with falls or ADRs, and this was attributed to inadequate recordings of these events in the CPRD database. Adjusted odds ratio (OR) found mortality risk associated with polypharmacy to be higher in women than men (OR 1.89 vs 1.73), in participants aged 75–85 years than 86 years and above (OR 1.77 vs 1.73), in those with ≥ 6 Potentially Inappropriate Medicines (PIMs) than those with less (OR 1.79 vs 1.64), and in those with 3-6 morbidities than 1–2 morbidities (OR 3.55 vs 1.67) (p < 0.05 for all). Hospitalization risk associated with polypharmacy was higher in patients aged 86 years and above than 75–85 years group (OR 3.08 vs 1.69) and in those with ≥ 6 PIMs than in those with less (OR 2.35 vs 2.19) (p < 0.05 for both). Overall, this study found polypharmacy to be a risk factor for mortality and hospitalizations in the short and long term. Future studies are needed to confirm these results. 

Click to read the study in PLOSONE

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Weighted vests and resistance training confer similar outcomes for bone density in the elderly

Breast cancer survivors may have a lower risk of Alzheimer’s dementia

Food compounds associated with disease activity in inflammatory bowel disease 

Tags: chronic diseaseelderlyfrailtygeriatric medicinepolypharmacy
Previous Post

Dazukibart is effective in reducing disease activity in adults with refractory dermatomyositis

Next Post

#VisualAbstract: Iptacopan Reduced Proteinuria in Patients with IgA Nephropathy

RelatedReports

Chronic Disease

Weighted vests and resistance training confer similar outcomes for bone density in the elderly

June 27, 2025
Chronic Disease

Breast cancer survivors may have a lower risk of Alzheimer’s dementia

July 2, 2025
Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease
Chronic Disease

Food compounds associated with disease activity in inflammatory bowel disease 

June 25, 2025
Weekly Rewinds

2 Minute Medicine Rewind June 23, 2025

June 23, 2025
Next Post
#VisualAbstract: Liraglutide for 56 Weeks plus lifestyle interventions reduced BMI and Body Weight in Children with Obesity

#VisualAbstract: Iptacopan Reduced Proteinuria in Patients with IgA Nephropathy

Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial

Magnetic resonance imaging provides important information regarding infarct topography in determining stroke mechanism and risk

Intensive rehabilitation not superior to traditional therapy for arm function after stroke

Endovascular therapy improves outcomes in vertebrobasilar stroke despite increased risk of bleeding

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence based clinical decision systems are safe and effective for diabetes management
  • Epic Launchpad propels generative-AI into everyday hospital routines
  • #VisualAbstract: Routine Cerebral Embolic Protection Did Not Reduce Stroke Incidence during Transcatheter Aortic-Valve Implantation
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.